Personalized protein corona on nanoparticles and its clinical implications-Reference-Cited by-同舟云学术

Personalized protein corona on nanoparticles and its clinical implications

Published:2017 Issue:3 Volume:5 Page:378-387
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Corbo Claudia¹²³⁴⁵^ORCID,Molinaro Roberto⁶⁷⁸⁵,Tabatabaei Mateen¹²³⁴⁵,Farokhzad Omid C.¹²³⁴⁵,Mahmoudi Morteza¹²³⁴⁵^ORCID

Affiliation:

1. Center for Nanomedicine and Department of Anesthesiology

2. Brigham and Women's Hospital

3. Harvard Medical School

4. Boston

5. USA

6. Center for Biomimetic Medicine

7. Houston Methodist Research Institute

8. Houston

Abstract

It is increasingly being accepted that the protein corona is strongly affected by the patient's specific disease. Therefore, the same nanomaterial incubated with plasma proteins of patients with different pathologies adsorb protein coronas with different compositions, giving rise to the concept of personalized protein corona.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2017/BM/C6BM00921B

Reference86 articles.

1. Biomolecular coronas provide the biological identity of nanosized materials

2. The “Sweet” Side of the Protein Corona: Effects of Glycosylation on Nanoparticle–Cell Interactions

3. Complete high-density lipoproteins in nanoparticle corona

4. Emerging understanding of the protein corona at the nano-bio interfaces

5. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors

Cited by 240 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy;WIREs Nanomedicine and Nanobiotechnology;2024-09

2. Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans;2024-07-27

3. Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights;Nano Research;2024-07-11

4. Thin Film Formation of HSA in the Presence of CTAB-Capped Gold Nanorods through Phase Separation;Langmuir;2024-07-02

5. The biomolecular corona of nanomedicines: effects on nanomedicine outcomes and emerging opportunities;Current Opinion in Biotechnology;2024-06